- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05811832
Evaluation in Elderly Individuals With Chronic Obstructive Pulmonary Disease(COPD)
Evaluation of Balance, Physical Activity, Functional Capacity and Activities of Daily Living in Frail Elderly Individuals With COPD
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Yasemin Köse
- Phone Number: +90 +905464682828
- Email: koseyasemin9928@gmail.com
Study Contact Backup
- Name: Döndü Nur Keskin
- Phone Number: +90 +905434833113
- Email: nurkskn-99@hotmail.com
Study Locations
-
-
Merkez
-
Kırıkkale, Merkez, Turkey, 71100
- Recruiting
- Kirikkale High Specialization Hospital
-
Contact:
- Selma Demir
- Phone Number: +905054895758
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Being diagnosed with COPD according to the Gold criteria
- Be over 65 years old
- Volunteering to participate in the study
- Not having mental and communication problems that prevent filling out the questionnaires to be used in the research.
- Not having an attack in the last 2 months
Exclusion Criteria:
- Being in a COPD exacerbation process
- Having been diagnosed with a physical and mental illness
- Having unstable COPD
- Unstabile angina, previous Myocardial Infractus, uncontrolled hypertension, cancer, with functional limitations concomitant neurological or musculoskeletal disorders
- Currently addicted to alcohol or drugs
- Having severe vision and hearing problems
- Have had major surgery in the last few months
- History of recurrent significant clinical infection
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Fragile elderly individuals with COPD
Patient evaluation form and socio-demographic form of all individuals participating in the study. properties will be questioned.To assess pulmonary functions at the assessment stage for all individuals pulmonary function test,Modified Medical Questionnaire to assess dyspnea research Council, to assess health-related quality of life, Saint George Respiratory Two Minute Walk Test to assess exercise capacity, frailty Frail fragility scale to detect fragility, Prisma-7 Vulnerability scale to assess fragility The scale is Pase to assess physical activity, Berg balance to assess balance. scale, digital hand dynamometer to evaluate quadriceps muscle strength, hand grip strength hand dynamometer to assess fatigue levels Fatigue Severity Scale will be used. |
Modified Medical research Council , Saint George Respiratory Two Minute Walk Test,Frail fragility scale ,Prisma-7 Vulnerability scale,Pase,Berg balance scale,manual muscle test,quadriceps muscle strength, hand dynamometer,Fatigue Severity Scale
|
Non-fragile elderly individuals with COPD
Patient evaluation form and socio-demographic form of all individuals participating in the study. properties will be questioned.To assess pulmonary functions at the assessment stage for all individuals pulmonary function test,Modified Medical Questionnaire to assess dyspnea research Council, to assess health-related quality of life, Saint George Respiratory Two Minute Walk Test to assess exercise capacity, frailty Frail fragility scale to detect fragility, Prisma-7 Vulnerability scale to assess fragility The scale is Pase to assess physical activity, Berg balance to assess balance. scale, digital hand dynamometer to evaluate quadriceps muscle strength, hand grip strength hand dynamometer to assess fatigue levels Fatigue Severity Scale will be used. |
Modified Medical research Council , Saint George Respiratory Two Minute Walk Test,Frail fragility scale ,Prisma-7 Vulnerability scale,Pase,Berg balance scale,manual muscle test,quadriceps muscle strength, hand dynamometer,Fatigue Severity Scale
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Berg balance scale(BDO)
Time Frame: eight months
|
The Berg balance scale (BDO) is a scale with 14 instructions and a score of 0-4 for each instruction by observing the patient's performance.
0 points are given when the patient is unable to perform the activity at all, while 4 points are given when the patient completes the activity independently.
The highest score is 56, with 0-20 points indicating a balance disorder, 21-40 points indicating the presence of an acceptable balance, and 41-56 points indicating the presence of a good balance.
|
eight months
|
Two-minute walk Test
Time Frame: eight months
|
It is recommended that the area where the test will be performed is a corridor with a flat and hard floor of 30 meters long.
The goal is to walk the maximum distance he can walk in 2 minutes if he has a helper device he uses.
If you have shortness of breath or fatigue, you are told to slow down and stop and then start again when you feel ready.
|
eight months
|
Physical activity scale for the elderly (PASE)
Time Frame: eight months
|
The survey assesses the physical activity of older individuals over the past week and includes components of leisure, housework, and work-related physical activity.
Never, rarely (1-2 days/week), sometimes (3-4 days/week) and often (5-7 days/week), while the duration of activities is classified as: Less than 1 hours, 1-2 hours to 2-4 hours and more than 4 hours.
|
eight months
|
Saint George Respiratory Survey
Time Frame: eight months
|
A test that assesses health-related quality of life specific to individuals with respiratory diseases.
questions 50 items divided into 3 areas: symptoms (8 items), activities (16 items), effects of the disease (26 items).
The 3 sections of the test are scored separately and the total score is calculated.
The scores vary from 0-100-0.
A score of zero indicates normal and a score of 100 indicates the worst state of health.
|
eight months
|
Modified Medical Research Council scale(MMRC)
Time Frame: eight months
|
The MMRC (modified Medical Research Council scale) is a scale scored between 0 and 4 based on various factors that produce a dyspnea sensation.
Zero points only shorten my breath during heavy exercise; 4 points I can't leave the house because of my shortness of breath or I have shortness of breath while getting dressed and undressed
|
eight months
|
Frail fragility scale
Time Frame: eight months
|
Proven to be an effective method of vulnerability detection.
The patient's fatigue status, resistance, mobility, weight loss and other diseases were questioned and allowed to evaluate.
The FRAIL scale, which consists of 5 items, scores 0 1-2 or 1 based on the patients' response and is evaluated as non-frail, 0 points pre-frail and >2 points fragile.
|
eight months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Breathing function test
Time Frame: eight months
|
Spirometry shows the maximum volume of air expelled by the challenging expiration (challenging vital capacity, FVC) from the maximum inspiration point and the volume of air expelled in the first second of this manoeuvre (1.
The challenging expiration volume per second, FEV 1) should be measured and these two measurement ratios (FEV 1/FVC) should be calculated.
Patients with COPD typically have both FEV 1 and FVC low.
When FEV 1/FVC < 70%, the postbronchodilator indicates the presence of a non-fully reversible airflow limitation when FEV 1 < 80% of what is expected.
|
eight months
|
Prisma-7 Vulnerability scale
Time Frame: eight months
|
The PRISMA-7 vulnerability scale is a seven-question survey recommended by the British Geriatric Association as a first-degree screening test.
The questions are answered in a yes/no way.
|
eight months
|
hand dynamometer
Time Frame: eight months
|
During the test, the patient sits in a sitting position in shoulder adduction, elbow in 90° flexion, forearm in neutral position, and measurements are performed three repetitions for the right and left sides.
It is recorded in kg or pounds as a unit.
The norm values for the measurement are 47-40 kg for men aged 20-69 years (2 kg less for the left hand) and 30-24 kg for women (1,5-2 kg less for the left hand).
|
eight months
|
digital hand dynamometer
Time Frame: eight months
|
For quadriceps strength measurement, the test is started when elderly people sit on a flat surface with their hips and knees in 90° flexion and feet in a free, unsupported position.
During the test, the "make test" technique, which requires isometric contraction, is applied.
All measurements are taken by the same researcher twice from both legs of the participants with the same hand.
|
eight months
|
Fatigue Severity Scale
Time Frame: eight months
|
Evaluates fatigue severity with 9 questions and scores are taken from 9 to 63 on the scale.
Each question is scored between 0 (I do not agree at all) and 7 (I totally agree).
A high score indicates increased fatigue intensity.
|
eight months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Yasemin Köse, Master of Science student
- Principal Investigator: Döndü Nur Keskin, Master of Science student
- Principal Investigator: İlayda Karabayır, Master of Science student
- Study Director: Meral Sertel, Associate professor lecturer
- Principal Investigator: Selma Demir, Specialist doctor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KirikkaleUniversity771
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COPD (Chronic Obstructive Pulmonary Disease)
-
University College, LondonUniversity of Cambridge; National Institute for Health Research, United Kingdom and other collaboratorsUnknownChronic Obstructive Pulmonary Disease (COPD).United Kingdom
-
Reham Mohammed ElmorshedyCompletedChronic Obstructive Pulmonary Disease(COPD)Egypt
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD).United Kingdom
-
Virginia Commonwealth UniversityFisher and Paykel HealthcareCompletedChronic Obstructive Pulmonary Disease(COPD)United States
-
Beaumont HospitalAerogenCompletedChronic Obstructive Pulmonary Disease | COPD | COPD Exacerbation | Copd Exacerbation AcuteIreland
-
Medtronic BRCUnknownCOPD | COPD Exacerbation
-
Chiesi Farmaceutici S.p.A.CompletedModerate to Severe Chronic Obstructive Pulmonary Disease (COPD)Bulgaria, Germany, Hungary, Poland, Russian Federation, United Kingdom
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary Disease (COPD) | COPDUnited Kingdom
-
Elpen Pharmaceutical Co. Inc.Completed
-
Aalborg UniversityCompletedChronic Obstructive Pulmonary Disease | COPD | COPD Exacerbation | COPD Exacerbation AcuteDenmark
Clinical Trials on Evaluation
-
IRCCS Eugenio MedeaCompletedIntellectual Disability | Autism Spectrum Disorder | Attention Deficit Hyperactivity DisorderItaly
-
University Hospital, BordeauxRoche Pharma AGRecruitingMultiple Sclerosis, Primary ProgressiveFrance
-
University Hospital, BordeauxRecruitingMultiple SclerosisFrance
-
University Hospital, CaenRecruitingDementia | Alzheimer Disease | Mild Cognitive Impairment | Motoric Cognitive Risk SyndromeFrance
-
University of CatanzaroAzienda Sanitaria Provinciale Di Catanzaro; Azienda Ospedaliera Universitaria...Unknown
-
Ankara Yildirim Beyazıt UniversityCompletedType 2 Diabetes Mellitus | BalanceTurkey
-
Wake Forest University Health SciencesAgency for Healthcare Research and Quality (AHRQ)Recruiting
-
Kırıkkale UniversityCompleted
-
Institut National de la Santé Et de la Recherche...Terminated